Real-time enrollment status for this early alzheimer's disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT06709014 |
| Recruiting Status | Recruiting |
| Condition | Early Alzheimer's Disease |
| Phase | Clinical Trial |
| Target Enrollment | 760 participants |
| Active Locations | 81 sites in the US |
| Sponsor | Annovis Bio Inc. |
| Last Updated on CT.gov | January 30, 2026 (Jan 30, 2026) |
As of March 2, 2026: Clinical trial NCT06709014 is currently recruiting participants. This clinical trial study for early alzheimer's disease is actively seeking new participants at 81 locations across the United States. The study is sponsored by Annovis Bio Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06709014 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 81 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06709014 was last updated Jan 30, 2026 (January 30, 2026). HelloStudys verifies this status automatically.